High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea

BACKGROUND: Persistence of Ebola virus (EBOV) in semen remains of deep concern, as sexual transmission of EBOV seems plausible up to 6 months after acute phase of Ebola virus disease (EVD). Favipiravir, a broad spectrum antiviral product, has been evaluated in reducing EVD mortality in Guinea in 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Eloy, Philippine, Laouénan, Cédric, Beavogui, Abdoul Habib, Keita, Sakoba, Manchon, Pauline, Etard, Jean-François, Sissoko, Daouda, Mentré, France, Malvy, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808076/
https://www.ncbi.nlm.nih.gov/pubmed/35127447
http://dx.doi.org/10.1016/j.idcr.2022.e01412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808076/
https://www.ncbi.nlm.nih.gov/pubmed/35127447
http://dx.doi.org/10.1016/j.idcr.2022.e01412

Ejemplares similares